Sign in
4

Changes in Ownership

Enveric Biosciences, Inc. Filed Acc 0000921895-17-001341

Options or other derivatives

  • Chief Financial Officer acquired 75,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Patel Viraj J Chief Financial Officer 2017-05-04 Grant or award · Option (Right to Buy) +75,000 75,000 D
Loading xslF345X03/form410211002_05082017.xml…